<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.9.2" -->
<rss version="0.92">
<channel>
	<title>MedCity News</title>
	<link>http://www.medcitynews.com</link>
	<description>MedCity News</description>
	<lastBuildDate>Fri, 12 Mar 2010 19:28:22 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Ohio House passes bill authorizing nurses to pronounce death</title>
		<description><![CDATA[The Ohio House of Representatives has overwhelmingly passed a proposal that authorizes registered nurses to determine and pronounce death.
Under current state law, only physicians have the authority to pronounce death. That&#8217;s a potential problem, given the well-chronicled physician shortage that exists in the U.S., which is more acute in rural areas. Giving nurses this authority [...]]]></description>
		<link>http://www.medcitynews.com/2010/03/ohio-house-passes-bill-authorizing-nurses-to-pronounce-death/</link>
			</item>
	<item>
		<title>Akron Children&#8217;s Hospital promotes finance chief</title>
		<description><![CDATA[Akron Children&#8217;s Hospital has promoted its interim chief financial officer to the full-time role.
Michael Trainer had served as the hospital&#8217;s interim CFO for the previous five months. He joined Akron Children&#8217;s in 2008 as a vice president, responsible for financial reporting and other related matters, according to a statement from the hospital.
A certified public accountant, [...]]]></description>
		<link>http://www.medcitynews.com/2010/03/akron-childrens-hospital-promotes-finance-chief/</link>
			</item>
	<item>
		<title>Morning Read: A controversial new type of health insurance in Oregon</title>
		<description><![CDATA[Highlights of the important and the interesting from the world of health care:
A controversial new type of health insurance in Oregon: Five Oregon health insurers are set to begin selling a new type of &#8220;carrot-and-stick&#8221; insurance plan that&#8217;s aimed at pushing employees towards more proven treatments and away from tests and surgeries that are deemed [...]]]></description>
		<link>http://www.medcitynews.com/2010/03/morning-read-a-controversial-new-type-of-health-insurance-in-oregon/</link>
			</item>
	<item>
		<title>Neoprobe readies for cancer drug NDA</title>
		<description><![CDATA[Neoprobe Corp. has talked to the U.S. Food and Drug Administration about Phase 3 clinical study results for its cancer-detection drug and is beginning its new drug application (NDA).
The Dublin, Ohio, developer of oncology, and surgical diagnostic and treatment products completed its Phase 3 trial of Lymphoseek in early December. In the trial, Lymphoseek was 97 percent successful [...]]]></description>
		<link>http://www.medcitynews.com/2010/03/neoprobe-readies-for-cancer-drug-nda/</link>
			</item>
	<item>
		<title>The hymn of skin</title>
		<description><![CDATA[In the March 3, 2010 issue of JAMA, there is a poem by Sarah Wells called “Hymn of Skin.”  While I enjoyed the whole poem, my favorite part is:
Plastic surgeon of the heavens, how I delight
in a furrowed brow, crow&#8217;s feet, age spots—
wrinkle me up a dozen times to show I lived
hard, good, funny—after all [...]]]></description>
		<link>http://www.medcitynews.com/2010/03/the-hymn-of-skin/</link>
			</item>
	<item>
		<title>Vilifying health insurers: a big mistake</title>
		<description><![CDATA[Remember the 1980s and early 90s? That’s when HMOs successfully  slowed or even reversed health care spending increases with tools such  as prior authorization, gatekeepers, restrictive drug formularies,  narrow networks and capitation. Employers were happy to save money and  also didn’t mind that the HMOs took the blame when patients were [...]]]></description>
		<link>http://www.medcitynews.com/2010/03/vilifying-health-insurers-a-big-mistake/</link>
			</item>
	<item>
		<title>Athersys executives excited about stem cell, drug programs</title>
		<description><![CDATA[Executives of biopharmaceutical company Athersys Inc. seem more confident than ever that their stem cell therapy MultiStem could eventually be used to profoundly help patients recover from heart attack, stroke and leukemia.
In a conference call with securities analysts late Thursday afternoon, the executives also disclosed promising research on drug candidates to treat obesity and attention-related [...]]]></description>
		<link>http://www.medcitynews.com/2010/03/athersys-executives-excited-about-stem-cell-drug-programs/</link>
			</item>
	<item>
		<title>Harvard Bioscience jumps into regenerative medicine</title>
		<description><![CDATA[When surgeons in Spain successfully replaced a young woman&#8217;s trachea in 2008, using a tissue-engineered windpipe researchers had grown out of her own stem cells, the world took notice.
David Green, the president of Harvard Bioscience Inc. (NSDQ:HBIO), a Holliston, Mass.-based lab instruments maker, also noticed. Green picked up the phone to call Italy shortly after [...]]]></description>
		<link>http://www.medcitynews.com/2010/03/harvard-bioscience-jumps-into-the-regenerative-medicine-market/</link>
			</item>
	<item>
		<title>STERIS not concerned about Breeden Capital board vacancy</title>
		<description><![CDATA[Robert Fields, a partner and managing director at Breeden Capital Management and Breeden Partners, quietly resigned from the STERIS Corp. board for personal reasons on March 5.
Normally, the resignation of a director causes few questions. However, Fields and Richard Breeden, the former U.S. Securities and Exchange Commission chief who has since become an investment manager [...]]]></description>
		<link>http://www.medcitynews.com/2010/03/steris-not-concerned-about-breeden-capital-board-vacancy/</link>
			</item>
	<item>
		<title>r4 Vascular releases new catheter for dialysis patients</title>
		<description><![CDATA[Device maker r4 Vascular will this week begin selling a new catheter that features a novel coating designed to prevent clotting.
The Duraspan catheter is intended for use by patients undergoing hemodialysis, a medical procedure in which a machine removes and cleans a patient&#8217;s blood then returns it to the body. A catheter is a thin, [...]]]></description>
		<link>http://www.medcitynews.com/2010/03/r4-vascular-releases-new-catheter-for-dialysis-patients/</link>
			</item>
</channel>
</rss>
